These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 7890486

  • 21. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA, Derkx FH, van den Meiracker AH.
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
    Chalon S, Moreno H, Hoffman BB, Blaschke TF.
    Clin Pharmacol Ther; 1999 Mar; 65(3):295-303. PubMed ID: 10096262
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
    Li P, Chappell MC, Ferrario CM, Brosnihan KB.
    Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms involved in the angiotensin II-independent hypotensive action of ACE inhibitors.
    Hecker M, Pörsti I, Busse R.
    Braz J Med Biol Res; 1994 Aug; 27(8):1917-21. PubMed ID: 7749381
    [Abstract] [Full Text] [Related]

  • 25. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K, Andersson RG.
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [Abstract] [Full Text] [Related]

  • 26. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ, Master RG, Fokin A, Baber SR, Kadowitz PJ.
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide.
    Brosnihan KB, Li P, Ferrario CM.
    Hypertension; 1996 Mar; 27(3 Pt 2):523-8. PubMed ID: 8613197
    [Abstract] [Full Text] [Related]

  • 28. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B, de Vries R, Saxena PR, Danser AH.
    Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries.
    Padmanabhan N, Jardine AG, McGrath JC, Connell JM.
    Circulation; 1999 Jun 08; 99(22):2914-20. PubMed ID: 10359736
    [Abstract] [Full Text] [Related]

  • 30. Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries.
    Flavahan S, Chang F, Flavahan NA.
    Am J Physiol Heart Circ Physiol; 2016 Sep 01; 311(3):H849-54. PubMed ID: 27422988
    [Abstract] [Full Text] [Related]

  • 31. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
    Félétou M, Germain M, Teisseire B.
    Am J Physiol; 1992 Mar 01; 262(3 Pt 2):H839-45. PubMed ID: 1558194
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
    Oliveira MA, Fortes ZB, Santos RA, Kosla MC, De Carvalho MH.
    Peptides; 1999 Mar 01; 20(10):1195-201. PubMed ID: 10573291
    [Abstract] [Full Text] [Related]

  • 37. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
    Schwieler JH, Kahan T, Nussberger J, Hjemdahl P.
    Acta Physiol Scand; 1994 Sep 01; 152(1):83-91. PubMed ID: 7810335
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of neutral endopeptidase by thiorphan does not modify coronary vascular responses to angiotensin I, angiotensin II and bradykinin in the isolated guinea pig heart.
    Kozlovski VI, Lomnicka M, Jakubowski A, Chlopicki S.
    Pharmacol Rep; 2007 Sep 01; 59(4):421-7. PubMed ID: 17901571
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.
    Hunley TE, Tamura M, Stoneking BJ, Nishimura H, Ichiki T, Inagami T, Kon V.
    Kidney Int; 2000 Feb 01; 57(2):570-7. PubMed ID: 10652034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.